Search bioRxiv⌕ Search

bioRxiv · 10.64898/2026.02.26.708416

Decomposing response inhibition: a POMDP model

Abstract

Inhibitory control is a core cognitive function whose competence varies across the population, with impairments often observed in psychiatric conditions such as attention deficit hyperactivity disorder (ADHD). The Stop Signal Task (SST) is a widely used paradigm for assessing this ability. However, conventional formalizations of SST performance, such as the independent race model, rely on assumptions that are frequently violated in modern experimental designs. Furthermore, they typically fit only mean reaction times, overlooking crucial trial-by-trial dynamics. To address these limitations, we formalize the SST as a partially observable Markov decision process (POMDP). This framework characterizes inhibitory control with two components: noisy perceptual inference regarding stimuli and optimal control balanced against potential costs. To fit this model to the Adolescent Brain Cognitive Development (ABCD) study baseline cohort (N = 3,567), we introduce Transformer-encoded Simulation-Based Inference (TeSBI). This end-to-end architecture learns compact, sequence-aware embeddings from raw behavioral data. It enables efficient, amortized inference of individual-level posteriors. Extensive validation confirms it extracts reliable and identifiable parameters. We identify distinct latent computational attributes associated with scores on ADHD questionnaires. Controlling for sex, IQ, and medication status, children with higher ADHD scores exhibit subtle but robust shifts in computational attributes. They show a reduction in go cue directional precision, alongside a blunted sensitivity to stop error, go error and time costs. The learned embedding space reveals a continuous manifold in which children with higher ADHD scores are heterogeneously distributed, rather than forming distinct disorder clusters. This indicates that similar clinical characteristics can emerge from diverse combinations of computational mechanisms, supporting a dimensional perspective on neurodiversity. Our end-to-end framework can be extended to a broader range of cognitive tasks. It offers a scalable, theory-driven solution for analyzing large-scale behavioral data.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Wang, W., Kaufmann, T., Dayan, P.. 2026-03-02. Decomposing response inhibition: a POMDP model. https://doi.org/10.64898/2026.02.26.708416

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗